Fig. 3From: Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancerRepresentative images from mice treated with CM-hUCESC, paclitaxel 10 mg/kg and the combination of paclitaxel 10 mg/kg + CM-hUCESC taken at 7 and 14 days and tumor volume which was determined by measuring luminescence since day 0 until day 21Back to article page